Multilateral Agreement M347 under section 1.5.1 of ADR on the carriage of monkeypox virus
(1) By derogation of Paragraph 2.2.62.1.4.1, Section 3.2.1. (Table A, Dangerous Goods List) and Chapter 4.1 of ADR, infectious substances containing monkeypox virus except for cultures of monkeypox virus may be carried under UN 3373 or UN 3291, as appropriate.
(2) The consignor shall include the following entry in the transport document: “Carriage in accordance with Multilateral Agreement M347”.
(3) This agreement shall be valid until 31 December 2025 for carriage on the territories of those ADR Contracting Parties signatory to this Agreement. If it is revoked before that date by one of the signatories, it shall remain valid until the above-mentioned date only for carriage on the territories of those ADR Contracting Parties signatory to this Agreement, which have not revoked it.
| COUNTRY | SIGNED | REVOKED |
| Germany | 27/06/2022 | |
| United Kingdom | 29/06/2022 | |
| Norway | 06/07/2022 | |
| Austria | 25/07/2022 | |
| Switzerland | 10/08/2022 | |
| Spain | 26/08/2022 |
Date of expiry: 1 January 2026
Add more in attachment
Collegati
ID 15815 | 20.02.2022 / Accordo in allegato
L'Italia sottoscrive l'Accordo multilaterale M343 in data 08.02.2022 inerente il trasporto di ter...
Il 18 Luglio 2013: l’Italia ha sottoscritto l’accordo multilaterale M260
Accordo multilaterale M260 conformemente alla sezione 1.5.1 dell’allegato A dell‘ADR concernente ...
ID 3745 | 02.12.2024 Aggiornato ADR 2025
Rev. 7.0 2024
Il Manuale, intende fornire un quadro generale dell'ADR, la normativa per il trasporto su strada di merci ...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
